AlzeCure Pharma AB (publ)
STO: ALZCUR.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Martin Jönsson
- Employees
- 11
- Headquarters
- Huddinge, Sweden
- IPO year
- 2018
- Market cap
- SEK 166.6M
- Website
- https://www.alzecurepharma.se
Loading ALZCUR…
Loading profile data…Frequently asked questions about ALZCUR
What does AlzeCure Pharma AB (publ) (ALZCUR.ST) do?
AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is developing drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its pipeline drug candidates include ACD856, which is in phase I...
Where does ALZCUR.ST trade?
AlzeCure Pharma AB (publ) (ALZCUR.ST) trades on the Stockholm Stock Exchange.
What sector is ALZCUR.ST in?
AlzeCure Pharma AB (publ) (ALZCUR.ST) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of AlzeCure Pharma AB (publ)?
Martin Jönsson is the chief executive officer of AlzeCure Pharma AB (publ) (ALZCUR.ST).
Where is AlzeCure Pharma AB (publ) headquartered?
AlzeCure Pharma AB (publ) is headquartered in Sweden.
Does ALZCUR.ST pay a dividend?
AlzeCure Pharma AB (publ) (ALZCUR.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALZCUR.ST go public?
AlzeCure Pharma AB (publ) (ALZCUR.ST) completed its initial public offering in 2018.